AMRN Amarin Corporation plc
Amarin Corporation plc (AMRN) is expected to report earnings on October 28, 2026, before the market open. The consensus earnings estimate is a loss of $0.33 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.6% since its last earnings release on July 29, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health.
Sector
Healthcare
Industry
Drug Delivery